Back to results
US 2014/0273204 A1Published application
Method Of Producing A Paralytic Peptide
AssigneeSoricimed Biopharma Inc.
InventorsJohn M. Stewart, Bradley J. Steeves, Karl Vernes
Life of this patent
Estimating the term…
Abstract
The invention relates to recombinant expression vectors encoding a low molecular weight peptide isolated from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent. This novel paralytic agent is useful as a neuromuscular blocker and analgesic or as an insecticide.
Claims20
A recombinant expression vector comprising a nucleic acid sequence encoding a peptide comprising all or part of the amino acid sequence (SEQ ID NO:
- 1), wherein the peptide has paralytic activity.
Dependencies are inferred from the claim text.